Regenerative medicine gets on a profitable roll

After getting off to a false start in the 1990s, the field of regenerative medicine has been reborn over the past decade. Now, several New England companies are showing that regenerative medicine generally defined as therapy that uses living cells to repair the body is more than just promising science. It can also be profitable.